Dry eye disease is a common eye condition that affects millions worldwide. It occurs when the eyes do not produce enough tears or the tears evaporate too quickly. The global dry eye disease market was valued at US$ XX billion in 2018 and is projected to reach US$ XX billion by 2027, growing at a CAGR of XX% during the forecast period. Key drivers of market growth include an aging population and increasing awareness of the condition. The market is segmented by product, treatment type, distribution channel, and region. North America currently dominates the market due to high rates of lifestyle diseases and availability of treatments.

1. Dry Eye Disease Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by
2027, at CAGR of XX% during forecast period of 2019 to 2027.
Dry eye disease is also known as Keratoconjunctivitis sicca is a common condition which can be
cured by treatment. Dry eye syndrome is an ocular disorder caused by the absence of tear fluid
to lubricate the eyes. Dry eye disease is one of the most common eye disorders around the world
and is particularly common in the elderly demographic.The report study has analyzed revenue
impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and
market disrupters in the report and same is reflected in our analysis.
Dry Eye Disease Market Drivers and Restrains
Common factors responsible for Dry Eye Disease, such as aging, systemic inflammatory diseases,
decrease in the supportive hormones, ocular surface diseases, or surgeries that affect the
cholinergic nerves, which stimulate tear secretion. They may be associated with the increasing

2. dry eye-related diseases. The global dry eye diseases market has also been boost up by the
increasing awareness among the population about this disease. Dry eye diseases is ignored by
many patients, since the troublesomeness caused by it is not debilitating. But, the increasing
awareness about the diagnosis and treatment of the disease has resulted in more patients
proactively trying to cure the syndrome, driving the global dry eye syndrome market. Stable
government support for medical research has permitted researchers to treat this condition more
comprehensively and precisely. Productive research in current year, which is helping the global
dry eye disease market to post a high growth rate. The popularity of self-medication by patients,
High cost and limited availability of effective therapeutics remains a main restraint on the dry eye
syndrome market at present. Furthermore, the expiration of patents on major drugs used in the
treatment of dry eye syndrome is a major restraint on the global dry eye syndrome market.
Manufacturers in the Dry Eye Disease are focusing on competitive pricing as the strategy to
capture significant market share. Moreover, strategic mergers and acquisitions and technological
innovations are also the key focus areas of the manufacturers.
Dry Eye Disease Market Segmentation Analysis
In terms of segmental analysis Dry Eye Disease Market is segmented into Product type,
Distribution Channel, Treatment, and Region. Based on the type, dry eye syndrome treatment
market is divided into aqueous dry eye syndrome and evaporative dry eye syndrome. In terms of
Product market is segmented into Artificial Tears, Anti-inflammatory Drugs, Punctal Plugs and
Secretagogue. According to the ARVO journal, evaporative dry eye disease is more common as
compared to aqueous dry eye disease. On the basis of the treatment, the market is segmented
into cyclosporine, corticosteroids, artificial tears, and punctual bags. According to the NCBI,
among dry eye patients over 65 years of age XX% apply artificial tears and XX % of them stayed
eye care professionals before starting any medications. Furthermore, on the basis of distribution
channels, the market is segmented as online pharmacies, hospital pharmacies, and retail
pharmacies.

3. Dry Eye Disease Market Regional Analysis
On the basis of region Dry Eye Disease Market divided into five region such as Asia Pacific, North
America, Europe, Latin America, and Middle East Africa. Among all the regions, North America
had hold the largest market share in 2018 and is projected to lead the market during the forecast
period. Because of presence of key market players associated with the dry eye syndrome
treatments and huge patient population. According to, America Journal of Ophthalmology, more
than XX million U.S. adults are treatment with dry eye disease. The high occurrence of lifestyle
disorders that rise the chances of contracting dry eye disease in this region is a major driver factor
for the North America. Medicines like pain relievers, antihistamines, and antidepressants, which
is proliferating in North America, also reportedly growth the risk of dry eye syndrome. Asia Pacific
is expected to be the second largest market over the forecast period and nearly follow by North
America in terms of profits.
The objective of the report is to present comprehensive analysis of Dry Eye Disease Market
including all the stakeholders of the industry. The past and current status of the industry with
forecasted market size and trends are presented in the report with the analysis of complicated
data in simple language. The report covers all the aspects of industry with dedicated study of key
players that includes market leaders, followers and new entrants by region. PORTER, SVOR,
PESTEL analysis with the potential impact of micro-economic factors by region on the market have
been presented in the report. External as well as internal factors that are supposed to affect the
business positively or negatively have been analyzed, which will give clear futuristic view of the
industry to the decision makers. The report also helps in understanding Dry Eye Disease Market
dynamics, structure by analyzing the market segments, and project the Dry Eye Disease Market
size. Clear representation of competitive analysis of key players by Dry Eye Disease Type, price,
financial position, product portfolio, growth strategies, and regional presence in the Dry Eye
Disease Market make the report investor’s guide.
Scope of the Dry Eye Disease Market
Dry Eye Disease Market, by Product

4. • Artificial Tears
• Anti-inflammatory Drugs
• Punctal Plugs
• Secretagogue
Dry Eye Disease Market, by Distribution Channel
• Hospital Pharmacies
• Independent Pharmacies and Drug Stores
• Online Pharmacies
Dry Eye Disease Market, by Type
• Evaporative Dry
• Aqueous Dry
Dry Eye Disease Market, by Treatment
• Cyclosporine
• Corticosteroids
• Lubricant Eye drops
• Punctual Bags
• Artificial Tears
• Drugs
Dry Eye Disease Market, by Region

5. • Asia Pacific
• North America
• Europe
• Latin America
• Middle East Africa
Dry Eye Disease Market, Major Players
• Novartis AG (Alcon)
• ALLERGAN
• Johnson & Johnson
• Vision Care
• Otsuka Pharmaceutical Vo. Ltd.
• Shire
• OASIS Medical
• Santen Pharmaceutical Co. Ltd.
• AFT Pharmaceuticals
• I-Med Pharma Inc.
• Sentiss Pharma Pvt. Ltd.
• Scope Ophthalmics Ltd.
• Sanofi Pasteur
• Serum Institute
• Bavarian Nordic

6. • CSL Ltd.
• Emergent Biosolutions, Inc.
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences
• Inovio Pharmaceuticals
• Novavax, Inc.
• SELLAS Life Sciences Group, Inc
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand.
This report can be personalized to meet your requirements. Get in touch with us and our
sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth
emerging opportunities & technologies as well as threats to the companies across the
Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and
Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Lumawant Godage
Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: sales@maximizemarketresearch.com
Address : Pune, Maharashtra 411051, India.

7. Contact: +919607195908